1
|
Synthesis and antiproliferative activity of 2,6-dibenzylamino-3,5-dicyanopyridines on human cancer cell lines.
|
Eur J Med Chem
|
2005
|
1.08
|
2
|
Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore.
|
J Med Chem
|
2006
|
0.97
|
3
|
Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors.
|
J Med Chem
|
2010
|
0.91
|
4
|
Synthesis and in vitro antitumoral activity of new N-phenyl-3-pyrrolecarbothioamides.
|
Bioorg Med Chem
|
2003
|
0.88
|
5
|
Synthesis of ibuprofen heterocyclic amides and investigation of their analgesic and toxicological properties.
|
Eur J Med Chem
|
2003
|
0.87
|
6
|
Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
|
J Antimicrob Chemother
|
2002
|
0.86
|
7
|
Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen.
|
Eur J Pharmacol
|
2013
|
0.86
|
8
|
Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide.
|
J Enzyme Inhib Med Chem
|
2012
|
0.85
|
9
|
Synthesis of new 2-arylamino-6-trifluoromethylpyridine-3-carboxylic acid derivatives and investigation of their analgesic activity.
|
Bioorg Med Chem
|
2004
|
0.82
|
10
|
2-Acylhydrazino-5-arylpyrrole derivatives: synthesis and antifungal activity evaluation.
|
Eur J Med Chem
|
2008
|
0.82
|
11
|
Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore.
|
Bioorg Med Chem
|
2007
|
0.82
|
12
|
Synthesis and evaluation of antitumoral activity of ester and amide derivatives of 2-arylamino-6-trifluoromethyl-3-pyridinecarboxylic acids.
|
Bioorg Med Chem
|
2007
|
0.82
|
13
|
Synthesis and evaluation of anticancer activity of 2-arylamino-6-trifluoromethyl-3-(hydrazonocarbonyl)pyridines.
|
Bioorg Med Chem
|
2009
|
0.81
|
14
|
Amidrazones as precursors of biologically active compounds--synthesis of diaminopyrazoles for evaluation of anticancer activity.
|
Arch Pharm (Weinheim)
|
2006
|
0.79
|
15
|
In vitro antimycobacterial activity of newly synthesised S-alkylisothiosemicarbazone derivatives and synergistic interactions in combination with rifamycins against Mycobacterium avium.
|
Int J Antimicrob Agents
|
2005
|
0.78
|
16
|
Synthesis and in vitro antitumoral activity of new hydrazinopyrimidine-5-carbonitrile derivatives.
|
Bioorg Med Chem
|
2005
|
0.77
|
17
|
Novel 2-amino-isoflavones exhibit aryl hydrocarbon receptor agonist or antagonist activity in a species/cell-specific context.
|
Toxicology
|
2012
|
0.77
|
18
|
Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins.
|
Bioorg Med Chem Lett
|
2012
|
0.76
|
19
|
Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain.
|
J Nucl Med
|
2011
|
0.75
|
20
|
Synthesis of new N-(2-(trifluoromethyl)pyridin-4-yl)anthranilic acid derivatives and their evaluation as anticancer agents.
|
Bioorg Med Chem Lett
|
2004
|
0.75
|
21
|
Synthesis and in vitro antitumoral activity of new 3,5-dicyanopyridine derivatives.
|
Bioorg Med Chem
|
2006
|
0.75
|
22
|
New bis(pyridyl)methane derivatives from 4-hydroxy-2-pyridones: synthesis and antitumoral activity.
|
Eur J Med Chem
|
2003
|
0.75
|
23
|
Synthesis and antimycobacterial activity of new S-alkylisothiosemicarbazone derivatives.
|
Bioorg Med Chem
|
2002
|
0.75
|